Pharma Knowledge Initiative

Presentations

Presentations

 The followings has been featured at seminars or published

  • Common Technical Documents for generic medicine
    2017/02/17
  • Regulatory considerations on decision making in early phase.
    2016/08/23
  • Regulatory Strategy Management in the development process from POC to NDA
    2016/07/15
  • Product Development Plan driven by regulatory strategy
    2016/05/23
  • NDA Dossier and Scenario Development
    2015/03/16
  • Working Knowledge for R&D Due Diligence
    2014/04/22
  • Practicalities of R&D Due Diligence for Research Acquisition
    2014/02/20
  • Basic Knowledge on Regulatory Strategy Development for
    Project Manager in Global Product Development
    2013/10/25
  • Making the most of Interview Meeting with PMDA & Points to
    be considered for desirable outcomes.
    2013/06/25
  • Unmet medical needs & Orphan drug designation in the context
    of Regulatory Strategy
    2013/01/24
  • Regulatory Strategy & Project Management of Global
    Pharmaceutical Development Process and Sourcing – Gap &
    Optimization between HQs and affiliates on strategic agenda
    2012/12/21
  • Clinical Trial Consultation in the context of enabling
    Registration Dossier
    2012/11/28
  • Regulatory Strategy Development in Global Pharmaceutical
    Development Process & Regulatory Souring
    2012/08/31
  • Registration Package & Communication with Regulator
    2012/06
  • Regulatory Strategy Development for Orphan Drug
    Designation & Application
    2012/05/24
  • Basic Knowledge and Skills for Regulatory Scientists in
    Pharmaceutical company
    2012/04/13
  • Briefing Documents & inquiries from PMDA
    2012/02/27
  • Roles of Regulatory Scientist for Business Opportunity
    Assessment & Portfolio Management
    2011/10/25
  • Business Tools & Working Knowledge for Regulatory Scientist
    2011/07/21